Predisposition to pediatric and hematologic cancers: a moving target.

Area of Science:

• Pediatric Oncology
• Cancer Genetics
• Hereditary Cancer Syndromes

Background:

• Hereditary cancer syndromes in pediatric, adolescent, and young adult populations are increasingly recognized.
• These syndromes exhibit a wide variation in tumor spectrum, including risks for hematologic malignancies.
• Understanding genetic mutations and clinical management is crucial for improving patient outcomes.

Purpose of the Study:

• To illustrate the molecular mechanisms of hereditary cancer syndromes in children and adults.
• To discuss adult-onset tumors in pediatric populations and their underlying hereditary causes.
• To explore leukemia predisposition syndromes and their diverse categories.

Main Methods:

• Review of molecular mechanisms in Li-Fraumeni syndrome, hereditary paraganglioma syndrome, DICER1 syndrome, and multiple endocrine neoplasia syndrome.
• Discussion of adult-onset tumors (basal cell carcinoma, colorectal cancer, medullary thyroid cancer, adrenal cortical carcinoma) in pediatric patients.
• Exploration of leukemia predisposition syndromes categorized by underlying mechanisms.

Main Results:

• Detailed illustration of molecular diversity in hereditary cancer syndromes.
• Identification of specific adult-onset tumors indicative of hereditary cancer syndromes in pediatric cases.
• Categorization of leukemia predisposition syndromes based on distinct biological pathways.

Conclusions:

• Enhanced understanding of hereditary cancer syndromes, their molecular basis, and tumor spectrum is vital.
• Clinical recognition, genetic testing, and early surveillance are key for managing these syndromes.
• This knowledge improves outcomes for young individuals with hereditary cancer predispositions.